Drug Information

Drug General Information
Drug ID
D0KI3F
Former ID
DNC014012
Drug Name
1-(4-bromooxazol-2-yl)-7-phenylheptan-1-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529603]
Structure
Download
2D MOL

3D MOL
Formula
C16H18BrNO2
Canonical SMILES
C1=CC=C(C=C1)CCCCCCC(=O)C2=NC(=CO2)Br
InChI
1S/C16H18BrNO2/c17-15-12-20-16(18-15)14(19)11-7-2-1-4-8-13-9-5-3-6-10-13/h3,5-6,9-10,12H,1-2,4,7-8,11H2
InChIKey
PCSNCSLGTDBRDM-UHFFFAOYSA-N
PubChem Compound ID
44554272
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529603]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529603Bioorg Med Chem Lett. 2008 Nov 15;18(22):5842-6. Epub 2008 Jun 28.Exploration of a fundamental substituent effect of alpha-ketoheterocycle enzyme inhibitors: Potent and selective inhibitors of fattyacid amide hydrolase.
Ref 529603Bioorg Med Chem Lett. 2008 Nov 15;18(22):5842-6. Epub 2008 Jun 28.Exploration of a fundamental substituent effect of alpha-ketoheterocycle enzyme inhibitors: Potent and selective inhibitors of fattyacid amide hydrolase.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.